Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Pericle

Showing results (1-10 of 23) with videos related to

Pageof 3
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)|November 15, 1996
CD44 is a cytotoxic triggering molecule on human polymorphonuclear cellsF Pericle, G Sconocchia, J A Titus, et al.
Blood|March 1, 1994
Lysis of neuroblastoma cell lines by human natural killer cells activated by interleukin-2 and interleukin-12A R Rossi, F Pericle, S Rashleigh, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 23, 1997
Immunocompromised tumor-bearing mice show a selective loss of STAT5a/b expression in T and B lymphocytesF Pericle, R A Kirken, V Bronte, et al.
Medical Oncology and Tumor Pharmacotherapy|January 1, 1993
Strategies for cytokine utilisation in tumor therapyF Di Pierro, F Cavallo, F Pericle, et al.
Journal of Leukocyte Biology|February 1, 1997
CD40-CD40L interactions provide "third-party" costimulation for T cell response against B7-1-transfected human breast tumor cellsF Pericle, P K Epling-Burnette, E R Podack, et al.
International Journal of Cancer|May 3, 1996
Direct killing of interleukin-2-transfected tumor cells by human neutrophilsF Pericle, R A Kirken, P K Epling-Burnette, et al.
Cancer Gene Therapy|February 24, 2001
Fusogenic activity of vesicular stomatitis virus glycoprotein plasmid in tumors as an enhancer of IL-12 gene therapyN K Eslahi, S Muller, L Nguyen, et al.
Blood|June 1, 1995
Role of extracellular adenosine triphosphate in the cytotoxic T-lymphocyte-mediated lysis of antigen presenting cellsD K Blanchard, S Wei, C Duan, et al.
Leukemia|October 25, 2013
Inhibition of JAK3 with a novel, selective and orally active small molecule induces therapeutic response in T-cell malignanciesJ A Ross, M Spadaro, D C Rosado, et al.
Natural Immunity and Cell Growth Regulation|January 1, 1991
Growth and dissemination of human malignant lymphoblasts in immunosuppressed nu/nu miceF Cavallo, C Riccardi, M Forni, et al.
Pageof 3

Showing results (1-10 of 23) with videos related to

Sort By:
Pageof 3
Journal of Immunology (Baltimore, Md. : 1950)|November 15, 1996
CD44 is a cytotoxic triggering molecule on human polymorphonuclear cellsF Pericle, G Sconocchia, J A Titus, et al.
Blood|March 1, 1994
Lysis of neuroblastoma cell lines by human natural killer cells activated by interleukin-2 and interleukin-12A R Rossi, F Pericle, S Rashleigh, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 23, 1997
Immunocompromised tumor-bearing mice show a selective loss of STAT5a/b expression in T and B lymphocytesF Pericle, R A Kirken, V Bronte, et al.
Medical Oncology and Tumor Pharmacotherapy|January 1, 1993
Strategies for cytokine utilisation in tumor therapyF Di Pierro, F Cavallo, F Pericle, et al.
Journal of Leukocyte Biology|February 1, 1997
CD40-CD40L interactions provide "third-party" costimulation for T cell response against B7-1-transfected human breast tumor cellsF Pericle, P K Epling-Burnette, E R Podack, et al.
International Journal of Cancer|May 3, 1996
Direct killing of interleukin-2-transfected tumor cells by human neutrophilsF Pericle, R A Kirken, P K Epling-Burnette, et al.
Cancer Gene Therapy|February 24, 2001
Fusogenic activity of vesicular stomatitis virus glycoprotein plasmid in tumors as an enhancer of IL-12 gene therapyN K Eslahi, S Muller, L Nguyen, et al.
Blood|June 1, 1995
Role of extracellular adenosine triphosphate in the cytotoxic T-lymphocyte-mediated lysis of antigen presenting cellsD K Blanchard, S Wei, C Duan, et al.
Leukemia|October 25, 2013
Inhibition of JAK3 with a novel, selective and orally active small molecule induces therapeutic response in T-cell malignanciesJ A Ross, M Spadaro, D C Rosado, et al.
Natural Immunity and Cell Growth Regulation|January 1, 1991
Growth and dissemination of human malignant lymphoblasts in immunosuppressed nu/nu miceF Cavallo, C Riccardi, M Forni, et al.
Pageof 3